Background: Train-of-four stimulation pattern following the administration of non-depolarizing neuromuscular blocking drugs reveals fade on successive contractions. Fade is caused by the release of fewer acetylcholine molecules by the fourth (A 4 ) than by the first stimulus (A 1 ). The current study was conducted to define the relationship between the clinically observed fade and the simulated decline in acetylcholine release (A 4 /A 1 ) that would be necessary to produce it.
Background
Non-depolarizing neuromuscular blocking drugs cause a dose-dependent decrease in the indirectly evoked muscle contractions (twitches). Upon repetitive stimulation, the successive twitches during partial nondepolarizing block are reduced more than the first twitch. This phenomenon is known as fade. The ratio of the twitch strength produced by the fourth stimulus (T 4 ) compared to that pro-duced by the first stimulus (T 1 ), i.e. T 4 /T 1 , elicited by a train-of-four (TOF) stimuli is of interest to both anesthesiologists and physiologists. Anesthesiologists use the T 4 / T 1 ratio as an indirect measure of the still present muscle paralysis [1] [2] [3] , while physiologists study the fade to gain insight into the processes of neuromuscular transmission [4] [5] [6] .
Bowman [7] and others [4, [8] [9] [10] have suggested that neuromuscular blocking drugs produce twitch fade during repetitive stimulation by binding to the presynaptic cholinoceptors and inhibiting the positive auto-feedback action of acetylcholine (ACh) on its own release elicited during repetitive stimulation. This action of neuromuscular blocking drugs causes the stimuli following the first stimulus to release fewer ACh molecules.
We have conducted the following study in an attempt to relate the clinically observed twitch fade, to the decrease in ACh that could account for the fade elicited by a train of four stimuli. In the first part of the investigation, we studied twitch depression and twitch fade in human subjects following the administration of different doses of vecuronium. In the second part, we expanded our model of neuromuscular transmission [11] by considering a decrease in the release of ACh elicited by the fourth stimulus.
Methods

Clinical experiments
After approval by the local IRB, 21 ASA physical status I or II, adult non-obese subjects scheduled for elective surgery consented to participate in the study. Following the i.v. administration of midazolam 1 -2 mg and fentanyl 3 -5 μg·kg -1 , anesthesia was induced with propofol 2 -3 mg· kg -1 . Tracheal intubation was performed following the topical application of lidocaine (4%, 3 ml). Anesthesia was maintained with propofol infusion (100-150 μg·kg -1· min -1 ) and 66% N 2 O in oxygen. Ventilation was controlled to maintain normocapnia.
The thumb of one hand was abducted (preload between 250 g and 300 g) and connected to a force transducer (Gould FT-10, Grass Telefactor, West Warwick, RI). The signal from the force transducer was amplified, digitized at 100 Hz, and recorded on a PC using PolyVIEW data acquisition and analysis software (version 2.5, Astro-Med, Inc., West Warwick, RI) for subsequent analysis.
Supramaximal stimuli were delivered to the ulnar nerve at the wrist via skin electrodes. Baseline stabilization was obtained by applying 1 Hz stimuli for 20 minutes. Following the stabilization period, the stimulation was changed to a TOF pattern, i.e. four supramaximal stimuli at 2 Hz, and the trains repeated at 12 s intervals. Vecuronium was injected in doses ranging from 15 μg·kg -1 to 80 μg·kg -1 . The doses were chosen to produce a wide range of twitch depression, including the complete ablation of T 1 . The recorded strengths of T 1 and T 4 were expressed as fractions of T 1 before the administration of vecuronium. The recordings were continued until complete spontaneous recovery from the neuromuscular block. The results are reported only for those subjects in whom T 1 returned to within ± 10% of the baseline.
Simulation of T 1 and T 4 as related to the release of acetylcholine by the first and the fourth stimuli The strength of the twitches elicited by the first and the fourth stimuli in a TOF stimulation pattern was simulated in the model of neuromuscular transmission [11] Binding of ACh to two sites at a postsynaptic receptor was defined by the association rate constant k association identical for both sites, k association = 1.35 × 10 8 M -1· s -1 . The assigned dissociation rate constants, k dissociation , were different: for site 1 k dissociation = 1350 s -1 , and for site 2 k dissociation = 13500 s -1 . The assignments define two equilibrium dissociation constants, K A1 = 10 -5 M for site 1 , and K A2 = 10 -4 M for site 2 . Affinities of ACh for the binding sites are the reciprocals of the equilibrium dissociation constants. After the release of ACh, three complexes are formed between ACh and the receptors: ARO, ORA, and ARA. Here, the first and the third letter indicate the species occupying site 1 and site 2 , A is ACh, O is an empty site, and R is the postsynaptic receptor. The complex ARA represents the activated postsynaptic receptors. The concentrations of all three complexes increase transiently after the release of ACh, reach a peak, and subsequently decline due to hydrolysis of free ACh. We assigned a first-order rate constant for hydrolysis of ACh (k hydrolysis ) at 12000 s -1 [11] .
The strength of T 1 or T 4 was calculated based on the assumption that a muscle fiber contracts when [ARA] reaches or surpasses the threshold level of [ARA] for that fiber [11] . The strength of T 1 
Results
Although 21 subjects were studied, the first twitch returned to within ± 10% of the baseline in only 15 subjects and only the data from these subjects are presented. Since our measurement technique did not allow us to measure twitch tension with precision once T 1 decreased to below 10% of its baseline value, we have not included in our analysis any data, be it for T 1 or T 4 /T 1 ratios, for T 1 < 0.1.
In all subjects studied, the peak depression of T 4 lagged behind the peak depression of T 1 , and the minimum T 4 was always lower than the minimum T 1 . This is illustrated for two subjects who received vecuronium doses of 15 μg·kg -1 or 35 μg·kg -1 , respectively (upper panel in Figure   1 ). The plot of T 4 /T 1 as a function of T 1 for the same two subjects reveals that, for any given value of T 1 , the T 4 /T 1 ratio is higher during the onset than during the offset of NMB (lower panel in Figure 1 ).
The T 4 /T 1 ratios as a function of T 1 for various doses of vecuronium during the onset of NMB are presented in the upper panel of Figure 2 . To simplify the presentation, only one representative subject is presented for each dose. The results indicate that, at any level of T 1 , the T 4 /T 1 ratios are higher, i.e. the twitch fade is less pronounced, with larger doses of vecuronium. Thus, at T 1 = 0. When compared at identical values of T 1 , the T 4 /T 1 ratios during the offset of NMB (lower panel in Figure 2 ) were lower than those observed during the onset. The ratios were similar among the different doses of vecuronium during the offset. Therefore, we have summarized the data for T 4 /T 1 during the offset of NMB at T 1 = 0.25, 0.5, 0.75, and 0.9, and present the mean ± SD in Figure 2 . (Figure 3 ).
Upper panel:
The ratios of the fourth to the first twitch (T 4 / T 1 ) as a function of T 1 
Discussion
Our finding that vecuronium produces less fade for any given twitch depression during the onset compared to the offset of NMB (Figure 2 ) is consistent with the findings reported by other investigators [12] [13] [14] [15] [16] . We have also found that, during the onset and at similar T 1 , larger doses of vecuronium produce less fade than smaller doses (Figure 2) . This finding is also consistent with the results from other investigations [14, 15] . During the offset of NMB, the pooled T 4 /T 1 -T 1 data pairs from all subjects (Figure 2 ) are similar to those reported by other investigators using vecuronium as well as other neuromuscular blocking drugs [12] [13] [14] [15] [16] .
The primary purpose of the present study was to correlate twitch fade, as observed in the current study and by the other investigators, with the decrease in ACh release that would be necessary to produce the fade. The simulations are based on the postulate by Bowman [7] that twitch fade is due to the decreased amount of ACh released by the fourth stimulus as compared to that released by the first We have previously investigated in simulations twitch fade caused by nondepolarizing muscle relaxants [17] . However, in that report we were interested in the properties of the muscle relaxants in relation to their interaction with the presynaptic receptors (the affinities and the rates of interaction). In the current study, our focus is on the estimate of the magnitude of the (Figure 3) , contradicts the suggestion that, even in the absence of neuromuscular blocking drugs, a spontaneous fall-off of the ACh quantal content occurs at 2 Hz stimulation frequency [18] . If there were a spontaneous fall-off in ACh quantal content upon repetitive stimulation, then in the presence of a drug that binds exclusively to the postsynaptic receptors, e.g. α-bungarotoxin or erabutoxin, the spontaneous fall-off in ACh release would, of necessity, lead to fade. However, it has been demonstrated repeatedly that these drugs produce a profound decrease in twitch height without producing fade [5, 6, 19] . Thus, the results of our simulations accord with, and support the notion of, no decline in ACh quantal content during the TOF pattern of stimulation in the absence of nondepolarizing neuromuscular blocking drugs [9, 20, 21] .
The results from our simulations suggest that fade, i.e. Figure 4 ) and, as a consequence, the T 4 /T 1 ratio is higher during the onset of the neuromuscular block following the larger doses of a muscle relaxant. 
Conclusion
The postulates that (i) the fourth stimulus releases fewer ACh molecules than the first, and (ii) the decrease in [A] 4 / [A] 1 develops slower than the decrease in T 1 , adequately explain the T 4 /T 1 -versus-T 1 relationship observed with vecuronium. The doses of vecuronium used in this study decrease the amount of ACh released by the fourth stimulus up to about 70% of the amount released by the first stimulus. However, the validity of these estimates is dependent on the validity of the assumptions made in simulations.
